EC Number |
Application |
Reference |
---|
3.5.1.92 | diagnostics |
enzyme Vnn1 is a valid biomarker for aggressive soft tissue sarcomas (STS) prognosis |
757538 |
3.5.1.92 | diagnostics |
potential use of vanin-1 as a marker of severity and therapeutic target in systemic sclerosis (SSc) |
-, 757352 |
3.5.1.92 | diagnostics |
usefulness of urinary vanin-1 with other biomarkers for the detection of renal complications in rats with experimental colitis |
-, 734049 |
3.5.1.92 | diagnostics |
vanin-1 is a biomarker of nephrotoxicant-induced kidney injury, increase in urinary vanin-1 is detected before the elevations of serum creatinine or urinary N-acetyl-beta-glucosaminidase, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin, in models of drug-induced acute kidney injury, overview |
-, 734537 |
3.5.1.92 | drug development |
the highly sensitive fluorescent assay for the hydrolysis of pantothenate-7-amido-4-methylcoumarin as substrate to pantothenic acid and 7-amino-4-methylcoumarin could be a powerful tool for target validation and drug lead identification and characterization |
710847 |
3.5.1.92 | medicine |
manipulation the Vanin-1/pantetheinase activity represents an attractive therapeutic strategy for the treatment of inflammatory bowel disease |
688102 |
3.5.1.92 | medicine |
the pantetheinase activity of vanin-1 molecule could be a target for a new anti-inflammatory strategy |
659573 |
3.5.1.92 | medicine |
vanin-1 is a potential biomarker for nephrotoxicant-induced renal injury |
721078 |